دسترسی نامحدود
برای کاربرانی که ثبت نام کرده اند
برای ارتباط با ما می توانید از طریق شماره موبایل زیر از طریق تماس و پیامک با ما در ارتباط باشید
در صورت عدم پاسخ گویی از طریق پیامک با پشتیبان در ارتباط باشید
برای کاربرانی که ثبت نام کرده اند
درصورت عدم همخوانی توضیحات با کتاب
از ساعت 7 صبح تا 10 شب
ویرایش: نویسندگان: Maureen F. Cooney, Ann Quinlan-Colwell سری: ناشر: Elsevier سال نشر: 2021 تعداد صفحات: 865 زبان: English فرمت فایل : PDF (درصورت درخواست کاربر به PDF، EPUB یا AZW3 تبدیل می شود) حجم فایل: 108 Mb
در صورت تبدیل فایل کتاب Assessment and Multimodal Management of Pain an Integrative Approach به فرمت های PDF، EPUB، AZW3، MOBI و یا DJVU می توانید به پشتیبان اطلاع دهید تا فایل مورد نظر را تبدیل نمایند.
توجه داشته باشید کتاب ارزیابی و مدیریت چندوجهی درد یک رویکرد یکپارچه نسخه زبان اصلی می باشد و کتاب ترجمه شده به فارسی نمی باشد. وبسایت اینترنشنال لایبرری ارائه دهنده کتاب های زبان اصلی می باشد و هیچ گونه کتاب ترجمه شده یا نوشته شده به فارسی را ارائه نمی دهد.
Front Cover Mini Title Assessment and Multimodal Management of Pain: An Integrative Approach Copyright Dedication Reviewers Contributors Foreword Acknowledgments Contents Half Title Chapter 1 The Evolution of Pain Assessment and Multimodal Analgesia as an Integrative Pain Management Approach Incidence and Prevalence of Pain Historical Perspective of Multimodal Pain Management Growth in Pain Research Early National Efforts to Address Pain Pain Assessment as the Foundation of Multimodal Analgesia Evolution of an Integrative Multimodal Approach for Pain Management (Multimodal Analgesia) (Multimodal Treatment) Early Support for Multimodal Analgesia The Increase in Opioid Prescribing Rise in Opioid-Related Complications Resurgence of Support for Integrative, Multimodal, Opioid-Sparing Approaches Drivers for Integrative, Multimodal, Opioid-Sparing Approaches Professional Organizations Centers for Disease Control and Prevention Guidelines The Joint Commission Enhanced Recovery After Surgery Society Guidelines Institute of Medicine Report National Pain Strategy Future Challenges and Opportunities for Multimodal Analgesia Within an Integrative Approach References Chapter 2 Importance of Multimodal Pain Management Physiologic Complications of Unrelieved Pain Psychosocial Implications of Unrelieved Pain Anxiety Depression Agitation Role of Multimodal Analgesia in the Perioperative Setting Role of Multimodal Analgesia in the Management of Chronic Pain Ethical Considerations Ethical Principles Autonomy Beneficence Nonmaleficence Doctrine of Double Effect Justice Veracity Fidelity Clinical Application Key Points Case Scenario References Chapter 3 Physiology of Pain Theories of Pain Gate Control Theory of Pain The Neuromatrix Theory of Pain Gain Control Theory Other Models Biopsychosocial Model Fear Avoidance Model Classifications of Pain Classification Based on Duration Classification Based on Mechanism Nociceptive Pain Neuropathic Pain Mixed Pain States Pain Physiology and Pathophysiology Physiologic Processing of Pain Transduction Transmission Perception Modulation Abnormal Processing of Pain: Neuropathic Pain and Hypersensitization Peripheral Mechanisms and Neuropathic Pain Central Mechanisms and Neuropathic Pain Neuroinflammation and Immune System Special Conditions Central Pain Chronic Regional Pain Syndrome Key Points Case Scenario References Chapter 4 Barriers to Effective Pain Management Patient Barriers Misconceptions The Meaning of Pain Culture and Beliefs Clinical Application Past Experiences With Pain Patient Expectations of Pain and Pain Control Fear Fear of Side Effects Fear of Substance Abuse or Misuse Fear of Appearing To Be Drug Seeking Health Care Literacy Family Access Issues Finances Transportation Residential Area Provider Barriers Culture Perception Education Clinician Experience Golden Rule Versus Platinum Rule System Barriers to Effective Pain Management Culture of the Organization Continuing Education of Clinicians Time Insurance Coverage Opportunities Key Points Case Scenario References Chapter 5 Introduction to Pain Assessment Importance of Pain Assessment Classification of Pain Differentiation of Acute From Chronic Pain Assessment of Pain Mechanisms Roles of the Health Team in Pain Assessment Timing and Frequency of Pain Assessment Discrepancies in Pain Assessment Hierarchy of Pain Assessment: Assessing Pain in Patients Who Cannot Self-Report Key Points Case Scenario References Chapter 6 Pain Assessment in Cognitively Intact Adults Accurate Pain Assessment Pain Assessment Mnemonics for use in Pain Assessment Components of a Comprehensive Pain Assessment Physiologic and Sensory Aspects of Pain Assessment Location Intensity Onset and Duration (Temporal Aspects) Quality Aggravating and Alleviating Factors Effects of Pain Pain Affect Psychosocial Cognition Mental Status Sociocultural Factors Health Literacy Environmental Factors Context of Care Pertinent History Medical History Mental Health History Substance Use Disorder Risk and History Patient Goal Conducting the Pain Assessment Assessment of Acute Pain Assessment of Chronic Pain Tools for Assessing Pain Clinically Important Changes Unidimensional Pain Assessment Tools Numeric Rating Scale Visual Analogue Scale Verbal Descriptor Scales Wong-Baker FACES Pain Rating Scale FACES Pain Scale (Revised) Iowa Pain Thermometer Colored Analogue Scale Multidimensional Pain Assessment Tools Clinically Aligned Pain Assessment Tool The Defense and Veterans Pain Rating Scale 2.0 McGill Pain Questionnaire Brief Pain Inventory PEG Scale Functional Pain Scale Chronic Pain Grade Scale Short-Form 36 Bodily Pain Scale Neuropathic Pain Assessment Leeds Assessment of Neuropathic Symptoms and Signs Neuropathic Pain Questionnaire Breakthrough Pain Assessment Alberta Breakthrough Pain Assessment Tool for Cancer Patients Breakthrough Pain Assessment Tool Italian Questionnaire for Breakthrough Pain Key Points Case Scenario References Appendix 6-1 Translations of the Numeric Rating Scale Appendix 6-2 Translations of Wong-Baker FACES Pain Rating Scale Chapter 7 Pain Assessment of Patients Who Cannot Self-Report Pain Pain Assessment of Patients Who Cannot Self-Report Pain Pain Assessment in Critically Ill Adults Who Cannot Self-Report Pain Pain Assessment and Intervention Notation Algorithm Nonverbal Pain Assessment Tool Adult Nonverbal Pain Score Behavioral Pain Scale The Critical Care Pain Observation Tool Patients With Delirium Who Cannot Self-Report Pain Patients With Dementia Who Cannot Self-Report Pain Pain Assessment Checklist for Seniors With Limited Ability to Communicate Pain Assessment in Advanced Dementia The Checklist of Nonverbal Pain Indicators (CNPI) Patients With Intellectual Disabilities Who Cannot Self-Report Pain The Revised Faces, Legs, Activity, Cries, Consolability Scale The Individualized Numeric Rating Scale The Non-Communicating Adult Pain Checklist Patients at the End of Life Who Cannot Self-Report Pain The Multidimensional Objective Pain Assessment Tool The Pain Assessment in Advanced Dementia Tool Newer Trends in Pain Assessment for Patients Who Cannot Self-Report Pain Bispectral Index Pupillary Reflex as a Physiologic Measure The Nociception Level Index Cautions Key Points Case Scenario References Chapter 8 Assessment of Factors Affecting Pain and Affected by Pain Sleep Insomnia Disorder Assessment of Sleep Quality Treatment of Sleep Disorders Obstructive Sleep Apnea Assessment of Sleep Apnea Anxiety and Depression Anxiety Anxiety Sensitivity Discomfort Intolerance Pain Anxiety Pain Catastrophizing Assessment of Anxiety Depression Assessment of Depression Suicide Ideation Family Assessment Financial Assessment Key Points Case Scenario References Chapter 9 Basic Concepts Involved with Administration of Analgesic Medications Patient Considerations Age Genetics Route Selection Oral Route Transmucosal Route Sublingual, Buccal, and Intranasal Rectal Route Gastrointestinal Stomal Route Vaginal Route Intravenous Route Subcutaneous Route Intramuscular Route Topical Intraarticular and Periarticular Injections Transdermal Neuraxial and Peripheral Nerve Routes Analgesic Dosing Considerations Equianalgesic Dosing Around-the-Clock Dosing Awakening Patients for Analgesic Administration Dosing to Pain Intensity Using Numbers or Word Descriptors Range Orders Therapeutic Duplication Key Points Case Scenario References Chapter 10 Nonopioid Analgesic Medications Aspirin and Nonsteroidal Antiinflammatory Drugs History Pharmacologic Effects Aspirin NSAIDs Indications for Use Aspirin NSAIDs Adverse Effects Bleeding and Gastrointestinal Adverse Effects Cardiovascular Adverse Effects Renal Adverse Effects Blood Pressure Adverse Effects Cognitive Adverse Effects Hepatic Adverse Effects FDA Warnings Safety Summary Nanopharmacology Dosing and Formulations Oral Parenteral Topical Salicylates and NSAIDs Other NSAID Routes Ophthalmic Route Intranasal Route Monitoring Patients Receiving NSAID Therapy Use in Special Populations Older Adults Patients With End-Stage Renal Disease Surgical Patients Patients Who Have Undergone Bariatric Surgery Orthopedic Patients Acetaminophen History Pharmacologic Effects Indications for Use Routes, Formulations, and Dosing Adverse Effects Hepatotoxicity Treatment of Hepatotoxicity FDA Warnings Monitoring of Patients Use in Special Populations Older Adults Patients With Liver Disease Patients With Impaired Renal Function Multimodal Use of Nonopioid Analgesics Key Points Case Scenario References Chapter 11 Opioid Analgesics Section 1 Opioid Pharmacology Background Opioid Receptors Discovery Nomenclature Opioid Receptor Signaling Factors Affecting Drug Response Pharmacodynamics Pharmacokinetics Absorption Distribution Metabolism Drug-Drug Interactions: Phase I Metabolism Drug-Drug Interactions: Phase II Metabolism Clearance Renal Excretion Pharmacogenomics Opioid Classes Phenanthrenes Phenylpiperadines Diphenylheptane Methadone Phenylpropylamines TraMADol Tapentadol Benzomorphans Key Points Section 2 Opioid Selection Indications and Use of Opioids Formulations Opioid-Related Labeling and Safety Practices Adverse Effects Assessment and Monitoring of Patients on Opioid Therapy Morphine Indications and Uses Routes and Formulations Pharmacologic Considerations Codeine Indications and Uses Routes and Formulations Pharmacologic Considerations Adverse Effects FentaNYL Parenteral FentaNYL Indications and Uses Pharmacologic Considerations Other Considerations Transmucosal FentaNYL Indications and Uses Pharmacologic Considerations Other Considerations Transdermal FentaNYL Indications and Uses Pharmacologic Considerations Other Considerations HYDROcodone Indications and Uses Routes and Formulations Pharmacologic Considerations Other Considerations Benzhydrocodone HYDROmorphone Indications and Uses Routes and Formulations Pharmacologic Considerations Meperidine Indications and Uses Adverse Effects Methadone Indications and Uses Routes and Formulations Pharmacologic Considerations Other Considerations Drug-Drug Interactions Levorphanol Indications and Uses Routes and Formulations Pharmacologic Considerations OxyCODONE Indications and Uses Routes and Formulations Pharmacologic Considerations Other Considerations OxyMORphone Indications and Uses Routes and Formulations Pharmacologic Considerations Other Considerations Other Mu Opioid Analgesics Alfentanil Indications and Uses Routes and Formulations Pharmacologic Considerations Other Considerations Remifentanil Indications and Uses Routes and Formulations Pharmacologic Considerations Other Considerations SUFentanil Indications and Uses Routes and Formulations Pharmacologic Considerations Other Considerations Dual-Mechanism Analgesics TraMADol Indications and Uses Pharmacologic Considerations Other Considerations Tapentadol Indications and Uses Routes and Formulations Pharmacologic Considerations Other Considerations Partial Mu Agonist Buprenorphine Indications and Uses Routes and Formulations Pharmacologic Considerations Other Considerations Mixed Agonist-Antagonist Opioids Opioid Antagonists Indications and Uses Routes and Formulations Pharmacologic Considerations Other Considerations Naloxone Indications and Uses Routes and Formulations Pharmacologic Considerations Other Considerations Key Points Section 3 Opioid Dosing Practices Initiation of Opioid Therapy Titration of Short-Acting Opioid Dose Titration of Short-Acting Opioids in Patients With Severe Acute Pain Use of Modified-Release Opioids Titration of Modified-Release Opioid Continuous Intravenous Opioid Infusions Opioid Rotation or Switch Rotating From Other Opioids to Methadone Buprenorphine Tapering and Discontinuing Opioid Therapy Opioid Safety in the Community Key Points Case Scenario References Chapter 12 Common Unintended Effects of Opioids Constipation Assessment of Opioid-Induced Constipation Prevention and Management of Opioid-Induced Constipation Pharmacologic Management Nonpharmacologic Management Xerostomia (Dry Mouth) Assessment Prevention and Management Opioid-Induced Nausea and Vomiting Assessment Prevention and Management Pharmacologic Management Nonpharmacologic Management Pruritus Assessment Prevention and Management of Opioid-Induced Pruritus Other Prevention and Management Considerations Urinary Retention Assessment for Urinary Retention Prevention and Management of Opioid-Related Urinary Retention Hypogonadism Assessment Prevention and Management of Opioid-Induced Hypogonadism Sedation Assessment Prevention and Management Myoclonus Assessment Prevention and Management Opioid-Induced Hyperalgesia Prevention Physical Dependence on Opioids Assessment Prevention and Management Opioid Tolerance Immune Suppressing Effect of Opioids Key Points Case Scenario References Chapter 13 Preventing Opioid-Induced Advancing Sedation and Respiratory Depression Opioids and Respiratory Function Normal Respiratory Physiology and the Effect of Opioids Advancing Sedation and Opioid-Induced Respiratory Depression Incidence Overview of Current Recommendations Identification of the Risk Factors Nonmodifiable Risk Factors Obstructive Sleep Apnea Screening for Obstructive Sleep Apnea Screening for Obesity Hypoventilation Syndrome Risk Factors Associated With Naloxone Administration Modifiable Risk Factors Timing of Care and Assessments Communication Within the Health Care Team Health Care Team and Institutional Policies and Procedures Associated Pharmacologic Factors Formulations of Opioid Medications and Risks Mechanisms of Delivery of Opioid Medications and Risks Clinician Boluses Continuous Intravenous Infusion Intravenous Patient-Controlled Analgesia Neuraxial Analgesia Epidural Analgesia Peripheral Regional Analgesia Wound Infiltration Analgesia Periarticular Injections Delivery Systems Combining Classes of Medications and Their Synergistic Effects Strategizing to Improve Safety for Patients at Risk Assessing the Patient for Risk Subjective Assessment of Risk Objective Assessment of Risk Detection Using Electronic Monitoring Devices Monitoring the Patient Procedures for Intermittent Nursing Assessment for All Patients on Opioids: Level of Sedation Pasero Opioid Sedation Scale Michigan Opioid Safety Score Richmond Sedation Scale Procedures for Intermittent Nursing Assessment for All Patients on Opioids: Respiratory Status Continuous Electronic Monitoring Pulse Oximetry Respiratory Rate Capnography Minute Ventilation Interventions After Assessment Summary Key Points Case Scenario Acknowledgments References Chapter 14 Opioid Use Disorder Substance Use Disorder and Opioid Use Disorder Pathophysiology of Substance Use Disorder Terminology Related to Substance Use Disorder Ethical Challenges to the Treatment of Pain in Patients With Comorbid Opioid Use Disorder Caring for Patients With Pain and Opioid Use Disorder Clinical Challenges of Treating Pain With Comorbid Opioid Use Disorder Risk Factors for Development of Opioid Use Disorder Treatment of Opioid Use Disorder Methadone Buprenorphine Naltrexone Pain and Opioid Use Disorder: Acute Care Setting Screening for Opioid Use Disorder in the Acute Care Setting Acute Pain Management of the Patient With Active Opioid Use Disorder Who Is Not in Active Treatment Acute Pain Management for Patients on Medication-Assisted Treatment Acute Pain Management for Patients on Methadone Maintenance Therapy Acute Pain Management for Patients on Buprenorphine Therapy Acute Pain Management for Patients on Naltrexone Acute Pain Management for Patients With Opioid Use Disorder in Recovery Without Medication-Assisted Treatment Acute Pain Management: Special Considerations Discharge Planning for Patients With Opioid Use Disorder Chronic Pain Management in Patients With Opioid Use Disorder Chronic Pain Management for Patients With Opioid Use Disorder on Medication-Assisted Treatment: Special Considerations Methadone Maintenance Therapy Buprenorphine Therapy Naltrexone Therapy Chronic Pain Management for Patients in Recovery Without the Use of Medication-Assisted Treatment Chronic Pain Management for Patients With Active Opioid Use Disorder Who Are Not in Recovery Strategies to Reduce Risk Universal Precautions Opioid Selection Designing a Safe Treatment Plan Overdose Prevention Additional Considerations Key Points Case Scenario References Chapter 15 Coanalgesic Medications Medication Selection Gabapentinoids Mechanism of Action Indications and Uses Gabapentinoids and Neuropathic Pain Gabapentinoids and Perioperative Pain Gabapentinoids and Prevention of Chronic Postsurgical Neuropathic Pain Pharmacokinetics Dosing and Routes Adverse Effects Monitoring of Patients Antidepressants Tricyclic Antidepressants Mechanism of Action Indications and Uses Pharmacokinetics Dosing Selection Adverse Effects Monitoring of Patients Serotonin Norepinephrine Reuptake Inhibitors Mechanism of Action Indications and Uses DULoxetine Venlafaxine Milnacipran SNRIs and Pain-Related Research Pharmacokinetics Dosing and Routes Adverse Effects Monitoring of Patients Alpha-Adrenergic Receptor Agonists Mechanism of Action Indications and Uses CloNIDine TiZANidine Dexmedetomidine Pharmacokinetics Dosing and Routes CloNIDine TiZANidine Dexmedetomidine Adverse Effects CloNIDine TiZANidine Dexmedetomidine Monitoring of Patients Corticosteroids Mechanism of Action Indications and Uses Dosing and Routes Adverse Effects Monitoring of Patients N-Methyl-d-Aspartate Receptor Antagonists Dextromethorphan Mechanism of Action Indications and Uses Pharmacokinetics Dosing and Routes Adverse Effects Monitoring of Patients Ketamine Mechanism of Action Indications and Uses Acute Pain Chronic Pain Pharmacokinetics Dosing and Routes Adverse Effects Monitoring of Patients Magnesium Mechanism of Action Indications and Uses Dosing and Routes Adverse Effects Monitoring of Patients Sodium Channel Blockers: Lidocaine and Mexiletine Lidocaine Mechanism of Action Indications and Uses Dosing and Routes Adverse Effects Monitoring of Patients Mexiletine Indications and Uses Dosing and Routes Adverse Effects Monitoring of Patients Muscle Relaxants Baclofen for Spasticity From Upper Motor Neuron Syndromes Mechanism of Action Indications and Uses Dosing and Routes Adverse Effects Monitoring of Patients Skeletal Muscle Relaxants for Muscular Pain and Spasms From Musculoskeletal Conditions Mechanism of Action Indications and Uses for Skeletal Muscle Relaxants for Peripheral Conditions Dosing and Routes Adverse Effects Monitoring of Patients Dronabinol, Nabilone, and Cannabidiol Mechanism of Action Indications and Uses Dosing and Routes Adverse Effects Monitoring of Patients Other Coanalgesic Medications Key Points Case Scenario References Chapter 16 Topical Analgesics for the Management of Acute and Chronic Pain Benefits of Topical Analgesics Types of Topical Analgesics Counter-irritants Capsaicin Capsaicin Application, Dosing, and Monitoring Salicylates Menthol Local Anesthetics Lidocaine Lidocaine Application, Dosing, and Monitoring Nonsteroidal Antiinflammatory Drugs Diclofenac Diclofenac Application, Dosing, and Monitoring Compound Analgesics Ketamine Amitriptyline Ketamine and Amitriptyline Combination CloNIDine Gabapentin Baclofen Opioids Key Points Case Scenario References Chapter 17 Patient-Controlled Analgesia General Concepts Advantages of Use Indications for Use Optimize Safety Within the Patient-Controlled Analgesia Process Clinician Education General Concepts Equipment-Related Education PCA by Proxy Patient and Family Education Appropriate Prescription Patient Selection Cognitive Factors to Consider Psychological Factors to Consider Physiologic Factors to Consider Prescription Components Modes of Administration Medications Administered Medications Frequently Administered by PCA Mu Agonist Opioids Local Anesthetics Medications Not Frequently Administered by PCA CloNIDine Neostigmine Ketamine Dexmedetomidine Technical Components of Prescription Medication Concentration Clinician Rescue Dose and Loading Dose Bolus Dose or Demand Dose Lockout Interval Hourly Maximum Basal or Continuous Infusion Rate Routes of Administration Intravenous Route Epidural Route Regional Route Subcutaneous Route Transdermal Route Oral or Enteral Route Intranasal Route Sublingual Route Inhalation Route Patient Assessment and Monitoring to Optimize Safety Respiratory Assessment Sedation Assessment Monitoring With Equipment Pulse Oximetry Capnography Evaluating Equipment to Optimize Patient Safety Infusion Tubing Authorized Agent–Controlled Analgesia Family-Controlled or Caregiver-Controlled Analgesia Nurse-Controlled Analgesia Key Points Case Scenario References Chapter 18 Regional Analgesia, Local Infiltration, and Pain Management Neuraxial Analgesia Principles of Neuraxial Analgesia Neuraxial Anatomy Vertebral Column Spinal Nerves Neuraxial Analgesic Interventions Neuraxial Analgesia Beneficial Effects of Neuraxial Analgesia Contraindications to Neuraxial Analgesia Neuraxial Analgesia Techniques Spinal (Subarachnoid or Intrathecal) Analgesia Epidural Analgesia Thoracic Epidural Analgesia Lumbar Epidural Analgesia Combined Spinal-Epidural Caudal Anesthesia Medications Used In Neuraxial Analgesia Basic Pharmacology of Neuraxial Opioid Analgesics Bioavailability Solubility Equianalgesic Dose Conversions Distribution Selected Opioid Analgesics Morphine Extended-Release Epidural Morphine HYDROmorphone FentaNYL SUFentanil Local Anesthetics Mechanism of Action Effects of Local Anesthetics Effects on Sensation and Motor Activity Vasodilatation Basic Chemical Structure Physiologic and Chemical Activity Absorption and Distribution Metabolism and Excretion of Local Anesthetics Local Anesthetic Choices Multimodal Analgesia Using Neuraxial Opioids and Local Anesthetics Coanalgesic Medications Used in Neuraxial Analgesia Epinephrine Alpha 2 -Adrenergic Agonists (CloNIDine and Dexmedetomidine) Administration of Neuraxial Medications Continuous Infusion Clinician-Administered Intermittent Bolus Patient-Controlled Epidural Analgesia Programmed Intermittent Epidural Bolus Unintended Effects of Neuraxial Analgesics Neuraxial Opioid Adverse Effects Unintended Effects of Neuraxial Local Anesthetics Allergic Reaction Local Anesthetic Neurotoxicity Local Anesthetic Systemic Toxicity Risk Factors for LAST Signs and Symptoms of LAST Strategies to Reduce Risks for LAST Treatment of LAST Cardiovascular Unintended Effects Hypotension Bradycardia Urinary Retention Motor Block Other Potential Complications Related to Neuraxial Analgesia Procedure-Related Complications Ineffective, Partial, or Incomplete Neuraxial Analgesia Dural Puncture and Postdural Puncture Headache Signs and Symptoms of PDPH Treatment of PDPH Direct Needle Trauma Epidural Catheter–Related Complications Epidural Catheter Migration Signs and Symptoms of Epidural Catheter Migration Neurologic Complications Associated With Neuraxial Analgesia Injection or Infusion of Neurotoxic Agents Infection Risk Factors for Neuraxial Infection Strategies to Reduce Risk for Neuraxial Infection Signs and Symptoms of Neuraxial Infection Treatment of Neuraxial Infection Epidural Hematoma Risk Factors for Epidural Hematoma Signs and Symptoms of Epidural Hematoma Diagnosis of Epidural Hematoma Treatment of Epidural Hematoma Regional Analgesia Overview of Truncal and Peripheral Regional Analgesia Peripheral Nerve Block Interventions Beneficial Effects of Peripheral Nerve Blocks Contraindications and Risks Associated With Peripheral Nerve Blocks Medications for Peripheral Nerve Blocks Administration of Peripheral Nerve Block Medications Management of Peripheral Nerve Block Catheters and Infusions Peripheral Nerve Blocks: Truncal Approaches Paravertebral Block Anatomy Indications Technique Considerations Erector Spinae Plane Indications Technique Considerations Pectoralis Indications Technique Considerations Transversus Abdominis Plane Indications Technique Considerations Quadratus Lumborum Indications Technique Considerations Peripheral Nerve Blocks: Extremity Approaches Interscalene Nerve Block Indications Interscalene Anatomy Technique Considerations Complications Supraclavicular Indications Technique Considerations Infraclavicular Indications Technique Considerations Axillary Indications Technique Considerations Femoral Indications Technique Considerations Fascia Iliaca Indications Technique Considerations Adductor Canal Indications Technique Considerations Sciatic Nerve Block Indications Technique Considerations Ankle Block Indications Technique Considerations Regional Analgesia Infusion Systems Tapering and Discontinuing Regional Analgesia Catheters Catheter Removal Preventing and Managing Regional Analgesia Infusion System Complications Minimizing Errors in Administration of Regional Anesthesia Local Infiltration Analgesia Additional Analgesic Procedures Involving Use of Local Anesthetics Key Points Case Scenario References Chapter 19 Interventional Approaches Anatomy of the Central Nervous System Spinal Pain Diagnostic Imaging Spinal Injections Epidural Corticosteroid Injections Indications Contraindications Research Facet Injections Medial Branch Blocks Neurotomy Contraindications Complications Facet Injections Complications of Radiofrequency Ablation Postprocedure Care Research Vertebral Body Augmentation Contraindications Complications Postprocedure Care Research Implantable Therapies Spinal Cord Stimulators Devices Patient Selection SCS Trial SCS Device Implantation Contraindications Precautions Complications Postimplantation Care Research Intrathecal Drug Delivery System Indications Patient Selection Devices Intrathecal Medications IDDS Trial Permanent Implantation Contraindications Complications Postprocedure Care Research Key Points Case Scenario Acknowledgement References Chapter 20 Exercise and Movement Fear of Pain With Movement Fear of Pain Fear-Avoidance Model Assessment of Fear of Pain With Movement Treatment of Fear of Pain With Movement Exercise-Induced Hypoalgesia Movement Movement When Recovering With Acute Pain Paleo Movement Movement With Chronic Pain The Feldenkrais Method Dance Movement Therapy Connection Dance Biodanza Exercise Isometric Exercise Pilates Exercise Land Aerobic Exercise Aquatic Exercise Strengthening Exercises Goldfish Exercise Tai Chi Yoga Physical Therapy Therapeutic Exercise Mechanical Modalities Passive Therapies Electrotherapeutic Modalities Patient Education for All Exercise and Movement Key Points Case Scenario References Chapter 21 Distraction and Relaxation Distraction Types of Distraction Evidence and Indications for Pain Management Humor Evidence and Indications for Pain Management Cautions Art, Coloring, Drawing, and Doodling Evidence and Indications for Pain Management Electronic Games Evidence and Indications for Pain Management Cautions Virtual Reality and Immersion or Immersive Virtual Reality Evidence and Indications for Pain Management Relaxation Breathing Activities Types of Relaxation Breathing Diaphragmatic Breathing Abdominal Breathing Yogic Breathing or Pranayama Alternate Nostril Breathing Square Breathing Lamaze Breathing Evidence and Indications for Pain Management Cautions Progressive Muscle Relaxation Evidence and Indications for Pain Management Cautions Music Therapy Music Therapy as a Profession Music Therapy and Multimodal Pain Management Indications Using Music for Pain Control Evidence and Indications for Pain Management Concerns, Cautions, and Contraindications Animal-Assisted Therapy Definitions Animal-Assisted Therapy Animal-Assisted Activity Indications for Animal-Assisted Therapy and Animal-Assisted Activity Evidence and Indications for Pain Management Cautions Guided Imagery Evidence and Indications for Pain Management Cautions and Contraindications Autogenic Training Evidence and Indications for Pain Management Contraindications Key Points Case Scenario References Chapter 22 Cognitive-Behavioral and Psychotherapeutic Interventions as Components of Multimodal Analgesic Pain Management Integrative, Interdisciplinary, and Multimodal Pain Treatment Interdisciplinary Pain Rehabilitation or Functional Restoration Programs Cognitive-Behavioral Therapy Goal Setting Identifying Maladaptive Thinking Cognitive Restructuring Problem-Solving Behavioral Activation (Graded Behavioral Activation) Exposure Therapy (Graded Exposure Therapy) Coping Skill Development Coping With Trigger Factors Relapse Prevention and Maintenance of Skills Evidence Supporting Cognitive-Behavioral Therapy for Pain Management Cautions and Contraindications The Activating Event Belief Consequence Model Evidence for Pain Management Acceptance and Commitment Therapy Evidence for Pain Management Biofeedback (Applied Psychophysiology) Evidence for Pain Management Mindfulness-Based Stress Management and Mindfulness-Based Cognitive Therapy Evidence for Pain Management Psychoeducation Evidence for Pain Management Key Points Case Scenario References Chapter 23 Energy Healing Therapies or Biofield Therapies as Components of Multimodal Analgesic Pain Management Reiki Indications Evidence for Pain Management Cautions Therapeutic Touch Evidence for Pain Management Cautions Healing Touch Evidence for Pain Management Cautions Acupuncture Evidence for Pain Management Caution Auricular Acupuncture Evidence for Pain Management Caution Acupressure Evidence for Pain Management Caution Key Points Case Scenario References Chapter 24 Manual Therapies for Pain Management Manual Therapy Osteopathy, Osteopathy Manual Medicine, or Osteopathic Manipulative Therapy Evidence for Pain Management Research Craniosacral Therapy Evidence for Pain Management Cautions Massage Therapy Evidence for Pain Management Cautions Reflexology Evidence for Pain Management Cautions Chiropractic Practice Evidence for Pain Management Cautions Myofascial Trigger Point Therapy Evidence for Pain Management Cautions Muscle Energy Technique Evidence for Pain Management Cautions Fascial Distortion Model Evidence for Pain Management Cautions Key Points Case Scenario Acknowledgments References Chapter 25 Spirituality as a Component of Multimodal Pain Management Spirituality Prayer Evidence for Pain Management Cautions Meditation Centering Prayer (Spiritual Meditation) Evidence for Pain Management Kabbalah (Qabalah) Evidence for Pain Management Loving Kindness Meditation Evidence for Pain Management Mindfulness Meditation Reflective Walking, Labyrinth Walking, and Movement Meditation Evidence for Pain Management Ridhwan School Diamond Approach Evidence for Pain Management Self-Realization Fellowship Evidence for Pain Management Tibetan Buddhist Meditation Evidence for Pain Management Transcendental Meditation Evidence for Pain Management Zen Buddhism/Ch’an Evidence for Pain Management General Cautions and Precautions Regarding Meditation Key Points Case Scenario References Chapter 26 Natural Products: Supplements, Botanicals, Vitamins, and Minerals as a Component of Multimodal Pain Management Dietary Supplements Botanicals and Herbs Cannabis (Cannabis sativa, Cannabis indica, and Cannabis indica) Evidence for Pain Management Cautions and Contraindications Contraindications Potential Interactions With Medications Cat’s Claw (Uncaria tomentosa) Evidence for Pain Management Cautions Contraindications Potential Interactions With Medications Cayenne (Capsicum frutescens) Devil’s Claw (Harpagophytum procumbens, Harpagophytum zeyheri) Evidence for Pain Management Cautions Contraindications Potential Interactions With Medications Feverfew (Tanacetum parthenium L.) Evidence for Pain Management Cautions Contraindications Potential Interactions With Medications Frankincense or Olibanum (Boswellia serrata) Evidence for Pain Management Cautions Contraindications Potential Interactions With Medications Ginger (Zingiber officinale Roscoe) Evidence for Pain Management Cautions Contraindications Potential Interactions With Medications Turmeric (Curcuma longa or Curcuma domestica) Evidence for Pain Management Cautions Contraindications Potential Interactions With Medications Willow Bark (Salicis cortex) and White Willow Bark (Salix alba) Evidence for Pain Management Cautions Contraindications Potential Interactions With Medications Other Herbs and Botanicals Used for Pain Management Brazilian arnica (Solidago chilensis) Butterbur (Petasites hybridus) Comfrey (Symphytum officinale L.) Ginseng (Panax ginseng) Myrrh (Commiphora molmol) St. John’s Wort (Hypericum perforatum) Pharmaconutrients: Nutritional Modulators of Pain Avocado and Soybean Unsaponifiables (Persea gratissma and Glycine max) (Piascledine) Evidence for Pain Management Cautions Contraindications Potential Interactions With Medications Bromelain (Ananas comosus) (Pineapple Plant) Evidence for Pain Management Cautions Contraindications Potential Interactions With Medications Flavocoxid Evidence for Pain Management Cautions Contraindications Potential Interactions With Medications Green Tea (Camellia sinensis) Evidence for Pain Management Cautions Contraindications Potential Interactions With Medications Honey Evidence for Pain Management Cautions Contraindications Potential Interactions With Medications Supplements Acetyl-l-Carnitine Evidence for Pain Management Cautions Contraindications Potential Interactions With Medications Coenzyme Q10 (Ubiquinone-10) Evidence for Pain Management Cautions Contraindications Potential Interactions with Medications Glucosamine Hydrochloride or Sulfate and Chondroitin Sulfate Evidence for Pain Management Cautions Contraindications Potential Interactions With Medications Hyaluronic Acid Evidence for Pain Management Cautions Contraindications Potential Interactions With Medications Lactic Acid–Producing Bacteria (Lactobacillus acidophilus, casei, fermentum, gasseri, johnsonii, paracasei, plantarum, reu ... Evidence for Pain Management Cautions Contraindications Potential Interactions With Medications Magnesium Evidence for Pain Management Cautions Contraindications Potential Interactions With Medications Methylsulfonylmethane Evidence for Pain Management Cautions Contraindications Potential Interactions With Medications Omega-3 Polyunsaturated Fatty Acids (Eicosapentaenoic Acid and Docosahexaenoic Acid) Evidence for Pain Management Cautions Contraindications Potential Interactions With Medications Vitamins B Vitamins Vitamin B1 (Thiamine) Evidence for Pain Management Cautions Contraindications Potential Interactions With Medications Vitamin B2 (Riboflavin) Evidence for Pain Management Cautions Contraindications Potential Interactions With Medications Vitamin B6 (Pyridoxine, Pyridoxal, and Pyridoxamine) Evidence for Pain Management Cautions Contraindications Potential Interactions With Medications Vitamin B9 (Folate or Folic Acid) Evidence for Pain Management Cautions Contraindications Potential Interactions With Medications B12 (Cyanocobalamin or Cobalamin) Evidence for Pain Management Cautions Contraindications Potential Interactions With Medications Vitamin B Complex and Combinations Evidence for Pain Management Cautions Contraindications Potential Interactions With Medications Vitamin D Evidence for Pain Management Cautions Contraindications Potential Interactions With Medications Vitamin E Evidence for Pain Management Cautions Contraindications Potential Interactions With Medications Key Points Case Scenario References Chapter 27 Additional Nonpharmacologic Interventions as Components of Multimodal Pain Management Aromatherapy Evidence for Pain Management Cautions Caring, Empathy, and Compassion by Caregivers Evidence for Pain Management Cautions Crossing Hands and/or Arms Over the Midline Evidence for Pain Management Cautions Dietary Choices Antiinflammatory Diet Evidence for Pain Management Cautions Ketogenic Diet Evidence for Pain Management Cautions Environmental Modifications Lighting Sound Temperature Position Evidence for Pain Management Caution Hypnosis Evidence for Pain Management Caution Mirror Therapy or Mirror Visual Feedback Therapy Evidence for Pain Management Mirror Visual Feedback Therapy and Other Chronic Pain Conditions Virtual Reality Mirror Visual Feedback Therapy Mirror Visual Feedback Therapy in Home Settings Mirror Visual Feedback Therapy and Referred Sensations Cautions for Using Mirror Visual Feedback Therapy Obesity and Weight Management Evidence for Pain Management Cautions Static Magnet Therapy Evidence for Pain Management Cautions Temperature Modalities Therapeutic Superficial Heat Evidence for Pain Management Cautions Contraindications Therapeutic Cold, Ice, Cryotherapy Evidence for Pain Management Cautions Contraindications Alternating or Contrasting Temperature Therapy Evidence for Pain Management Cautions Valsalva Maneuver Evidence for Pain Management Cautions Contraindications Key Points Case Scenario References Chapter 28 Improving Institutional Commitment for Effective Multimodal Pain Management Organizational Commitment to Quality and Pain Management Customer Satisfaction Patient Safety Clinical Care Organizational Initiatives to Support Quality of Safe and Effective Multimodal Pain Management Interdisciplinary Pain Oversight Committee Medication Safety Committee Opioid Risk Initiatives and Safety Interventions Naloxone Availability Quality Improvement Plan-Do-Study-Act Lean Methodology A3 Methodology A3: Pitfalls Clinical Research Programs Clinical Nursing Efforts to Support Organizational Initiatives Nursing Shared Governance Pain Resource Nurse Program Education of Clinicians Future Opportunities for Improvement Innovation Resources for Guiding Improvements in Institutional Commitment to Safe and Effective Pain Management Key Points Case Scenario References Appendix: Terminology Index